Related Experiment Video
Updated: Mar 25, 2026

13:08
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
19.5K
Liquid plasma versus thawed plasma: Tracking coagulation factor activity changes during storage
Nalan Yurtsever1, Catherine Gereg1, Nichelle Perera1
1Department of Laboratory Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
Vox Sanguinis
|March 23, 2026
Summary
Liquid plasma (LQP) offers a viable alternative for emergency transfusions, showing comparable fibrinogen and protein C levels to thawed plasma (TP). While some factors like Factor V and Protein S are lower, LQP maintains stability for critical use.
Area of Science:
- Transfusion Medicine
- Hematology
- Biochemistry
Background:
- Liquid plasma (LQP) presents a longer shelf-life alternative to thawed plasma (TP) for emergent transfusions.
- Assessing coagulation factor levels in LQP is crucial for its clinical application.
Purpose of the Study:
- To measure key coagulation factor activities (fibrinogen, Protein C, Protein S, Factor V, Factor VII, Factor VIII) in LQP.
- To quantify changes in these factor levels during LQP storage.
- To compare coagulation factor activity between LQP and TP.
Main Methods:
- Coagulation factor activities were measured in LQP (n=26) on days 15 and 26, and in TP (n=31) on day 5.
- Bayesian statistics were employed to compare factor activities and assess storage-related changes.
Main Results:
- LQP on day 26 showed comparable fibrinogen and Protein C activity to TP on day 5.
- Lower activities were observed in LQP for Factor V, Factor VII, Factor VIII, and significantly lower for Protein S.
- Factor VII activity in LQP decreased by 3.49% daily from day 15 to 26, while other factors remained stable.
Conclusions:
- Liquid plasma (LQP) demonstrates comparable fibrinogen, Protein C, and Factor VII levels to thawed plasma (TP).
- Lower Factor V and Protein S, and slightly lower Factor VIII activities were noted in LQP.
- LQP is a viable alternative for emergency and massive transfusion protocols.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.3K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K
Coagulation
11.9K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
11.9K
Coagulation
1.6K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.6K
Protein Buffers in Blood Plasma and Cells
4.4K
The human body utilizes protein buffer systems to maintain a stable pH. These systems capitalize on the dual role of amino acids, which can act as acids or bases by accepting or releasing hydrogen ions in response to pH changes. Protein buffer systems are particularly significant in the extracellular fluid (ECF) and intracellular fluid (ICF) of active cells, where structural and functional proteins provide substantial buffering capacity.
Certain amino acids can exist in a zwitterion state at a...
Certain amino acids can exist in a zwitterion state at a...
4.4K

